← Evidence map

ArticlePloS one2020

INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models.

Phillip C C Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

85 papers cite itlatest 60 shown

2020
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32315352